Home > Financial Ratios > VAISHALI PHARMA

VAISHALI PHARMA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for VAISHALI PHARMA
Please provide your vote to see the results

VAISHALI PHARMA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -68.1133.8294.6045.00-24.35

What is the latest Core EBITDA Growth ratio of VAISHALI PHARMA ?

The latest Core EBITDA Growth ratio of VAISHALI PHARMA is -68.11 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024-68.11
Mar202333.82
Mar202294.60
Mar202145.00
Mar2020-24.35

How is Core EBITDA Growth of VAISHALI PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2024 -68.11
Negative
Mar2023 33.82
-64.25
Mar2022 94.6
110.22
Mar2021 45
Positive
Mar2020 -24.35 -

Other Financial Ratios of VAISHALI PHARMA


Compare Core EBITDA Growth ratio of peers of VAISHALI PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VAISHALI PHARMA ₹165.2 Cr 3.9% -1.5% -27.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹392,195.0 Cr 0.3% -4% -6.3% Stock Analytics
DIVIS LABORATORIES ₹159,417.0 Cr 2% -9.6% 33.1% Stock Analytics
CIPLA ₹124,867.0 Cr 1.9% 4.5% -0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹123,971.0 Cr 0.6% 3.6% 9.2% Stock Analytics
DR REDDYS LABORATORIES ₹103,956.0 Cr 2% -1% -7% Stock Analytics


VAISHALI PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VAISHALI PHARMA

3.9%

-1.5%

-27.4%

SENSEX

2%

0.1%

1.8%


You may also like the below Video Courses